<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   2181
  </number>
  <updateDate>
   2023-01-11T13:48:03Z
  </updateDate>
  <updateDateIncludingText>
   2023-01-11T13:48:03Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-03-23
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 54 (Tuesday, March 23, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. WELCH:H.R. 2181.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 18: The Congress shall havePower To . . . make all Laws which shall be necessary andproper for carrying into Execution the foregoing Powers, andall other Powers vested by this Constitution in theGovernment of the United States, or in any Department orOfficer therof. .[Page H1622]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hsif00
    </systemCode>
    <name>
     Energy and Commerce Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-03-24T15:29:05Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-03-23T15:02:15Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <relatedBills>
   <item>
    <title>
     Affordable and Safe Prescription Drug Importation Act
    </title>
    <congress>
     117
    </congress>
    <number>
     920
    </number>
    <type>
     S
    </type>
    <latestAction>
     <actionDate>
      2021-03-23
     </actionDate>
     <text>
      Committee on Health, Education, Labor, and Pensions Subcommittee on Primary Health and Retirement Security. Hearings held.
     </text>
    </latestAction>
    <relationshipDetails>
     <item>
      <type>
       Identical bill
      </type>
      <identifiedBy>
       CRS
      </identifiedBy>
     </item>
    </relationshipDetails>
   </item>
   <item>
    <title>
     Affordable Medications Act
    </title>
    <congress>
     117
    </congress>
    <number>
     1898
    </number>
    <type>
     S
    </type>
    <latestAction>
     <actionDate>
      2021-05-27
     </actionDate>
     <text>
      Read twice and referred to the Committee on Finance.
     </text>
    </latestAction>
    <relationshipDetails>
     <item>
      <type>
       Related bill
      </type>
      <identifiedBy>
       CRS
      </identifiedBy>
     </item>
    </relationshipDetails>
   </item>
  </relatedBills>
  <actions>
   <item>
    <actionDate>
     2021-03-24
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Health.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-03-23
    </actionDate>
    <text>
     Referred to the House Committee on Energy and Commerce.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsif00
      </systemCode>
      <name>
       Energy and Commerce Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-03-23
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-03-23
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     W000800
    </bioguideId>
    <fullName>
     Rep. Welch, Peter [D-VT-At Large]
    </fullName>
    <firstName>
     Peter
    </firstName>
    <lastName>
     Welch
    </lastName>
    <party>
     D
    </party>
    <state>
     VT
    </state>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     B001224
    </bioguideId>
    <fullName>
     Rep. Bush, Cori [D-MO-1]
    </fullName>
    <firstName>
     Cori
    </firstName>
    <lastName>
     Bush
    </lastName>
    <party>
     D
    </party>
    <state>
     MO
    </state>
    <district>
     1
    </district>
    <sponsorshipDate>
     2021-03-23
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     D000399
    </bioguideId>
    <fullName>
     Rep. Doggett, Lloyd [D-TX-35]
    </fullName>
    <firstName>
     LLOYD
    </firstName>
    <lastName>
     DOGGETT
    </lastName>
    <party>
     D
    </party>
    <state>
     TX
    </state>
    <district>
     35
    </district>
    <sponsorshipDate>
     2021-03-23
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     N000147
    </bioguideId>
    <fullName>
     Del. Norton, Eleanor Holmes [D-DC-At Large]
    </fullName>
    <firstName>
     ELEANOR
    </firstName>
    <lastName>
     NORTON
    </lastName>
    <party>
     D
    </party>
    <state>
     DC
    </state>
    <middleName>
     HOLMES
    </middleName>
    <district>
     0
    </district>
    <sponsorshipDate>
     2021-03-23
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     P000607
    </bioguideId>
    <fullName>
     Rep. Pocan, Mark [D-WI-2]
    </fullName>
    <firstName>
     Mark
    </firstName>
    <lastName>
     Pocan
    </lastName>
    <party>
     D
    </party>
    <state>
     WI
    </state>
    <district>
     2
    </district>
    <sponsorshipDate>
     2021-03-23
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     K000389
    </bioguideId>
    <fullName>
     Rep. Khanna, Ro [D-CA-17]
    </fullName>
    <firstName>
     Ro
    </firstName>
    <lastName>
     Khanna
    </lastName>
    <party>
     D
    </party>
    <state>
     CA
    </state>
    <district>
     17
    </district>
    <sponsorshipDate>
     2021-03-23
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     N000191
    </bioguideId>
    <fullName>
     Rep. Neguse, Joe [D-CO-2]
    </fullName>
    <firstName>
     Joe
    </firstName>
    <lastName>
     Neguse
    </lastName>
    <party>
     D
    </party>
    <state>
     CO
    </state>
    <district>
     2
    </district>
    <sponsorshipDate>
     2021-03-23
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     O000173
    </bioguideId>
    <fullName>
     Rep. Omar, Ilhan [D-MN-5]
    </fullName>
    <firstName>
     Ilhan
    </firstName>
    <lastName>
     Omar
    </lastName>
    <party>
     D
    </party>
    <state>
     MN
    </state>
    <district>
     5
    </district>
    <sponsorshipDate>
     2021-03-23
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     S001145
    </bioguideId>
    <fullName>
     Rep. Schakowsky, Janice D. [D-IL-9]
    </fullName>
    <firstName>
     JANICE
    </firstName>
    <lastName>
     SCHAKOWSKY
    </lastName>
    <party>
     D
    </party>
    <state>
     IL
    </state>
    <middleName>
     D.
    </middleName>
    <district>
     9
    </district>
    <sponsorshipDate>
     2021-03-23
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     B000574
    </bioguideId>
    <fullName>
     Rep. Blumenauer, Earl [D-OR-3]
    </fullName>
    <firstName>
     EARL
    </firstName>
    <lastName>
     BLUMENAUER
    </lastName>
    <party>
     D
    </party>
    <state>
     OR
    </state>
    <district>
     3
    </district>
    <sponsorshipDate>
     2021-03-26
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     G000559
    </bioguideId>
    <fullName>
     Rep. Garamendi, John [D-CA-3]
    </fullName>
    <firstName>
     John
    </firstName>
    <lastName>
     Garamendi
    </lastName>
    <party>
     D
    </party>
    <state>
     CA
    </state>
    <district>
     3
    </district>
    <sponsorshipDate>
     2021-03-26
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     P000597
    </bioguideId>
    <fullName>
     Rep. Pingree, Chellie [D-ME-1]
    </fullName>
    <firstName>
     Chellie
    </firstName>
    <lastName>
     Pingree
    </lastName>
    <party>
     D
    </party>
    <state>
     ME
    </state>
    <district>
     1
    </district>
    <sponsorshipDate>
     2021-03-26
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     R000606
    </bioguideId>
    <fullName>
     Rep. Raskin, Jamie [D-MD-8]
    </fullName>
    <firstName>
     Jamie
    </firstName>
    <lastName>
     Raskin
    </lastName>
    <party>
     D
    </party>
    <state>
     MD
    </state>
    <district>
     8
    </district>
    <sponsorshipDate>
     2021-03-26
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     G000551
    </bioguideId>
    <fullName>
     Rep. Grijalva, Raúl M. [D-AZ-3]
    </fullName>
    <firstName>
     Raúl
    </firstName>
    <lastName>
     Grijalva
    </lastName>
    <party>
     D
    </party>
    <state>
     AZ
    </state>
    <middleName>
     M.
    </middleName>
    <district>
     3
    </district>
    <sponsorshipDate>
     2021-05-07
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     M001214
    </bioguideId>
    <fullName>
     Rep. Mrvan, Frank J. [D-IN-1]
    </fullName>
    <firstName>
     Frank
    </firstName>
    <lastName>
     Mrvan
    </lastName>
    <party>
     D
    </party>
    <state>
     IN
    </state>
    <middleName>
     J.
    </middleName>
    <district>
     1
    </district>
    <sponsorshipDate>
     2022-04-14
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     J000306
    </bioguideId>
    <fullName>
     Rep. Jones, Mondaire [D-NY-17]
    </fullName>
    <firstName>
     Mondaire
    </firstName>
    <lastName>
     Jones
    </lastName>
    <party>
     D
    </party>
    <state>
     NY
    </state>
    <district>
     17
    </district>
    <sponsorshipDate>
     2022-05-10
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     C001068
    </bioguideId>
    <fullName>
     Rep. Cohen, Steve [D-TN-9]
    </fullName>
    <firstName>
     Steve
    </firstName>
    <lastName>
     Cohen
    </lastName>
    <party>
     D
    </party>
    <state>
     TN
    </state>
    <district>
     9
    </district>
    <sponsorshipDate>
     2022-06-03
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <policyArea>
   <name>
    Health
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects>
    <item>
     <name>
      Administrative law and regulatory procedures
     </name>
    </item>
    <item>
     <name>
      Canada
     </name>
    </item>
    <item>
     <name>
      Congressional oversight
     </name>
    </item>
    <item>
     <name>
      Department of Health and Human Services
     </name>
    </item>
    <item>
     <name>
      Drug safety, medical device, and laboratory regulation
     </name>
    </item>
    <item>
     <name>
      Government information and archives
     </name>
    </item>
    <item>
     <name>
      Government studies and investigations
     </name>
    </item>
    <item>
     <name>
      Prescription drugs
     </name>
    </item>
    <item>
     <name>
      Trade restrictions
     </name>
    </item>
    <item>
     <name>
      User charges and fees
     </name>
    </item>
   </legislativeSubjects>
   <policyArea>
    <name>
     Health
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-03-23
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2021-07-07T21:23:48Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;strong&gt;Affordable and Safe Prescription Drug Importation Act&lt;/strong&gt;&lt;/p&gt; &lt;p&gt;This bill allows expanded importation of eligible prescription drugs and addresses related issues.&lt;/p&gt; &lt;p&gt;Current law allows the Department of Health and Human Services (HHS) to authorize the importation of certain eligible prescription drugs from Canada if HHS certifies to Congress that doing so would pose no additional risk to public health and safety and would result in significant cost savings for consumers. The bill removes this certification requirement and requires HHS to issue regulations that permit the importation of qualifying prescription drugs from Canada. After a certain amount of time, HHS may authorize importation from certain other countries if it determines that importation from Canada has resulted in cost savings for consumers and increased access to safe medication.&lt;/p&gt; &lt;p&gt;The bill also expands the types of prescription drugs eligible for importation to include, for example, biologics such as insulin. &lt;/p&gt; &lt;p&gt;Furthermore, the bill allows individuals to use an eligible licensed foreign pharmacy to fill a U.S.-issued prescription for a qualifying drug for personal use. Currently, an individual seeking to import a prescription drug generally must acquire a waiver from HHS. &lt;/p&gt; &lt;p&gt;The bill imposes various requirements related to certification of foreign sellers, labeling of imported drugs, and supply chain security. &lt;/p&gt; &lt;p&gt;The bill also (1) prohibits certain acts that discriminate against foreign sellers, such as charging higher prices to foreign sellers than to other sellers in the same country; and (2) imposes criminal penalties for online websites that sell counterfeit drugs or dispense drugs without a required prescription.&lt;br /&gt; &lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   Affordable and Safe Prescription Drug Importation Act
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     Affordable and Safe Prescription Drug Importation Act
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     Affordable and Safe Prescription Drug Importation Act
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-03-23T04:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr2181ih/xml/BILLS-117hr2181ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-03-24
   </actionDate>
   <text>
    Referred to the Subcommittee on Health.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

2021-03-24
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-03-23
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-03-23
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-03-23
9
Library of Congress
Introduced in House
IntroReferral
2021-03-23T15:02:15Z
Referred to
House
Energy and Commerce Committee
2021-03-24T15:29:05Z
Referred to
Health Subcommittee
hsif14
hsif00
Standing
B001224
1
Cori
Rep. Bush, Cori [D-MO-1]
Bush
D
2021-03-23
MO
D000399
35
LLOYD
Rep. Doggett, Lloyd [D-TX-35]
DOGGETT
D
2021-03-23
TX
N000147
0
ELEANOR
Del. Norton, Eleanor Holmes [D-DC-At Large]
NORTON
HOLMES
D
2021-03-23
DC
P000607
2
Mark
Rep. Pocan, Mark [D-WI-2]
Pocan
D
2021-03-23
WI
K000389
17
Ro
Rep. Khanna, Ro [D-CA-17]
Khanna
D
2021-03-23
CA
N000191
2
Joe
Rep. Neguse, Joe [D-CO-2]
Neguse
D
2021-03-23
CO
O000173
5
Ilhan
Rep. Omar, Ilhan [D-MN-5]
Omar
D
2021-03-23
MN
S001145
9
JANICE
Rep. Schakowsky, Janice D. [D-IL-9]
SCHAKOWSKY
D.
D
2021-03-23
IL
B000574
3
EARL
Rep. Blumenauer, Earl [D-OR-3]
BLUMENAUER
D
2021-03-26
OR
G000559
3
John
Rep. Garamendi, John [D-CA-3]
Garamendi
D
2021-03-26
CA
P000597
1
Chellie
Rep. Pingree, Chellie [D-ME-1]
Pingree
D
2021-03-26
ME
R000606
8
Jamie
Rep. Raskin, Jamie [D-MD-8]
Raskin
D
2021-03-26
MD
G000551
3
Raúl
Rep. Grijalva, Raúl M. [D-AZ-3]
Grijalva
M.
D
2021-05-07
AZ
M001214
1
Frank
Rep. Mrvan, Frank J. [D-IN-1]
Mrvan
J.
D
2022-04-14
IN
J000306
17
Mondaire
Rep. Jones, Mondaire [D-NY-17]
Jones
D
2022-05-10
NY
C001068
9
Steve
Rep. Cohen, Steve [D-TN-9]
Cohen
D
2022-06-03
TN
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-03-23
2021-03-24
Referred to the Subcommittee on Health.
House
Health
2021-03-23
Committee on Health, Education, Labor, and Pensions Subcommittee on Primary Health and Retirement Security. Hearings held.
CRS
Identical bill
Affordable and Safe Prescription Drug Importation Act
S
2021-05-27
Read twice and referred to the Committee on Finance.
CRS
Related bill
Affordable Medications Act
S
W000800
Peter
Rep. Welch, Peter [D-VT-At Large]
N
Welch
D
VT
Administrative law and regulatory procedures Canada Congressional oversight Department of Health and Human Services Drug safety, medical device, and laboratory regulation Government information and archives Government studies and investigations Prescription drugs Trade restrictions User charges and fees
2021-03-23
Introduced in House
 <p><strong>Affordable and Safe Prescription Drug Importation Act</strong></p> <p>This bill allows expanded importation of eligible prescription drugs and addresses related issues.</p> <p>Current law allows the Department of Health and Human Services (HHS) to authorize the importation of certain eligible prescription drugs from Canada if HHS certifies to Congress that doing so would pose no additional risk to public health and safety and would result in significant cost savings for consumers. The bill removes this certification requirement and requires HHS to issue regulations that permit the importation of qualifying prescription drugs from Canada. After a certain amount of time, HHS may authorize importation from certain other countries if it determines that importation from Canada has resulted in cost savings for consumers and increased access to safe medication.</p> <p>The bill also expands the types of prescription drugs eligible for importation to include, for example, biologics such as insulin. </p> <p>Furthermore, the bill allows individuals to use an eligible licensed foreign pharmacy to fill a U.S.-issued prescription for a qualifying drug for personal use. Currently, an individual seeking to import a prescription drug generally must acquire a waiver from HHS. </p> <p>The bill imposes various requirements related to certification of foreign sellers, labeling of imported drugs, and supply chain security. </p> <p>The bill also (1) prohibits certain acts that discriminate against foreign sellers, such as charging higher prices to foreign sellers than to other sellers in the same country; and (2) imposes criminal penalties for online websites that sell counterfeit drugs or dispense drugs without a required prescription.<br /> </p>
2021-07-07T21:23:48Z
00
2021-03-23T04:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr2181ih/xml/BILLS-117hr2181ih.xml
Affordable and Safe Prescription Drug Importation Act
Affordable and Safe Prescription Drug Importation Act
Display Title
IH
Introduced in House
To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals.
Official Title as Introduced
IH
Introduced in House
Affordable and Safe Prescription Drug Importation Act
Short Title(s) as Introduced
HR
2023-01-11T13:48:03Z
2023-01-11T13:48:03Z
3.0.0
2021-03-23
Committee on Health, Education, Labor, and Pensions Subcommittee on Primary Health and Retirement Security. Hearings held.
CRS
Identical bill
Affordable and Safe Prescription Drug Importation Act
S
2021-05-27
Read twice and referred to the Committee on Finance.
CRS
Related bill
Affordable Medications Act
S
2021-03-24
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-03-23
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-03-23
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-03-23
9
Library of Congress
Introduced in House
IntroReferral
W000800
Peter
Rep. Welch, Peter [D-VT-At Large]
N
Welch
D
VT
B001224
1
Cori
Rep. Bush, Cori [D-MO-1]
Bush
D
2021-03-23
MO
D000399
35
LLOYD
Rep. Doggett, Lloyd [D-TX-35]
DOGGETT
D
2021-03-23
TX
N000147
0
ELEANOR
Del. Norton, Eleanor Holmes [D-DC-At Large]
NORTON
HOLMES
D
2021-03-23
DC
P000607
2
Mark
Rep. Pocan, Mark [D-WI-2]
Pocan
D
2021-03-23
WI
K000389
17
Ro
Rep. Khanna, Ro [D-CA-17]
Khanna
D
2021-03-23
CA
N000191
2
Joe
Rep. Neguse, Joe [D-CO-2]
Neguse
D
2021-03-23
CO
O000173
5
Ilhan
Rep. Omar, Ilhan [D-MN-5]
Omar
D
2021-03-23
MN
S001145
9
JANICE
Rep. Schakowsky, Janice D. [D-IL-9]
SCHAKOWSKY
D.
D
2021-03-23
IL
B000574
3
EARL
Rep. Blumenauer, Earl [D-OR-3]
BLUMENAUER
D
2021-03-26
OR
G000559
3
John
Rep. Garamendi, John [D-CA-3]
Garamendi
D
2021-03-26
CA
P000597
1
Chellie
Rep. Pingree, Chellie [D-ME-1]
Pingree
D
2021-03-26
ME
R000606
8
Jamie
Rep. Raskin, Jamie [D-MD-8]
Raskin
D
2021-03-26
MD
G000551
3
Raúl
Rep. Grijalva, Raúl M. [D-AZ-3]
Grijalva
M.
D
2021-05-07
AZ
M001214
1
Frank
Rep. Mrvan, Frank J. [D-IN-1]
Mrvan
J.
D
2022-04-14
IN
J000306
17
Mondaire
Rep. Jones, Mondaire [D-NY-17]
Jones
D
2022-05-10
NY
C001068
9
Steve
Rep. Cohen, Steve [D-TN-9]
Cohen
D
2022-06-03
TN
Administrative law and regulatory procedures Canada Congressional oversight Department of Health and Human Services Drug safety, medical device, and laboratory regulation Government information and archives Government studies and investigations Prescription drugs Trade restrictions User charges and fees
2021-03-23
Introduced in House
 <p><strong>Affordable and Safe Prescription Drug Importation Act</strong></p> <p>This bill allows expanded importation of eligible prescription drugs and addresses related issues.</p> <p>Current law allows the Department of Health and Human Services (HHS) to authorize the importation of certain eligible prescription drugs from Canada if HHS certifies to Congress that doing so would pose no additional risk to public health and safety and would result in significant cost savings for consumers. The bill removes this certification requirement and requires HHS to issue regulations that permit the importation of qualifying prescription drugs from Canada. After a certain amount of time, HHS may authorize importation from certain other countries if it determines that importation from Canada has resulted in cost savings for consumers and increased access to safe medication.</p> <p>The bill also expands the types of prescription drugs eligible for importation to include, for example, biologics such as insulin. </p> <p>Furthermore, the bill allows individuals to use an eligible licensed foreign pharmacy to fill a U.S.-issued prescription for a qualifying drug for personal use. Currently, an individual seeking to import a prescription drug generally must acquire a waiver from HHS. </p> <p>The bill imposes various requirements related to certification of foreign sellers, labeling of imported drugs, and supply chain security. </p> <p>The bill also (1) prohibits certain acts that discriminate against foreign sellers, such as charging higher prices to foreign sellers than to other sellers in the same country; and (2) imposes criminal penalties for online websites that sell counterfeit drugs or dispense drugs without a required prescription.<br /> </p>
2021-07-07T21:23:48Z
00
Affordable and Safe Prescription Drug Importation Act
Affordable and Safe Prescription Drug Importation Act
Display Title
IH
Introduced in House
To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals.
Official Title as Introduced
IH
Introduced in House
Affordable and Safe Prescription Drug Importation Act
Short Title(s) as Introduced
2021-03-24
Referred to the Subcommittee on Health.